Ashley Richards
Nurse Practitioner · Columbus, OHNPI 1982248522
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $786 and has fallen 95.5% since, to $35 in 2025.
Across 83 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$255
- Jazz Pharmaceuticals Inc.$202
- SK Life Science, Inc.$163
- Biogen$111
- Lilly USA, LLC$102
- AstraZeneca$92
- plus $675 from 21 others
What the payments were for
- Food & beverage$1,600100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $255 |
| Jazz Pharmaceuticals Inc. | 9 | $202 |
| SK Life Science, Inc. | 7 | $163 |
| Biogen | 6 | $111 |
| Lilly USA, LLC | 5 | $102 |
| AstraZeneca(2 entities) | 5 | $92 |
| Sanofi | 5 | $82 |
| Biohaven Pharmaceuticals, Inc. | 3 | $77 |
| Genentech USA, Inc. | 6 | $61 |
| Revance Therapeutics, Inc. | 1 | $54 |
| Galderma Laboratories, L.p. | 3 | $49 |
| Lundbeck LLC | 2 | $47 |
| Johnson & Johnson | 2 | $32 |
| Philips North America LLC | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| GE HealthCare | 2 | $24 |
| Novartis | 1 | $23 |
| UCB, Inc. | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Banner Life Sciences, LLC | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Acorda Therapeutics, Inc | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Mallinckrodt Hospital Products Inc. | 1 | $12 |
How this compares
$1,600 in reported general payments places this provider in the 85th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 18 | $794 |
| Donepezil Hcl | 21 | $204 |
| Sertraline Hcl | 22 | $90 |
| Duloxetine Hcl | 14 | $83 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Columbus
- Katherine AlexanderColumbus$99K
- Cynthia MilichColumbus$13K
- Dawn HaqueColumbus$11K
- Jena WilkinsonColumbus$10K
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Tiffany JonesCincinnati$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.